Daniel Salevitz , Madison Ransdell , Chung-Yon Lin , Gwen Grimsby
{"title":"Analyzing the Patterns of Industry Payments in Urology: A Benchmark Comparison With Other Surgical Specialties","authors":"Daniel Salevitz , Madison Ransdell , Chung-Yon Lin , Gwen Grimsby","doi":"10.1016/j.urology.2025.05.043","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>To examine differences in industry payments across multiple surgical specialties and to examine differences in payments to pediatric urologists (PU) with other urologic subspecialists (UO).</div></div><div><h3>Methods</h3><div>The 2022 Open Payments dataset was downloaded from the Center for Medicare and Medicaid website. Industry payments were collected for urologists, otolaryngologists (ENT), orthopedic<span> (Ortho), and plastic (Plastics) surgeons for comparison. Descriptive statistics with Kruskal-Wallis and chi-square tests were performed to evaluate payment distributions across these specialties and between PU and OU.</span></div></div><div><h3>Results</h3><div>In 2022, industry payments were reported to 9686 urologists. Ortho received the highest number and dollar amount of payments, with 315,664 payments valuing nearly $600 million. Urologists received 207,961 payments at $33.5 million, Plastics with 58,446 at $93 million, and ENT with 70,006 payments and $13.7 million. The specialties had statistically significantly different distribution of payments in total number and amount of money paid (<em>P</em> <.0001). PU received 906 payments and $162,826, versus OU with 207,055 payments valuing $33.4 million, and the distribution of these payments was also significantly different (<em>P</em> <.0001).</div></div><div><h3>Conclusion</h3><div>The distribution of payments differed significantly across the surgical sub-specialties examined. There was also a staggering difference in industry payments between PU and other urologists, which highlights a disparity in interactions between medical device and pharmaceutical companies even within the specialty of urology.</div></div>","PeriodicalId":23415,"journal":{"name":"Urology","volume":"203 ","pages":"Pages 101-107"},"PeriodicalIF":2.0000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0090429525005035","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
To examine differences in industry payments across multiple surgical specialties and to examine differences in payments to pediatric urologists (PU) with other urologic subspecialists (UO).
Methods
The 2022 Open Payments dataset was downloaded from the Center for Medicare and Medicaid website. Industry payments were collected for urologists, otolaryngologists (ENT), orthopedic (Ortho), and plastic (Plastics) surgeons for comparison. Descriptive statistics with Kruskal-Wallis and chi-square tests were performed to evaluate payment distributions across these specialties and between PU and OU.
Results
In 2022, industry payments were reported to 9686 urologists. Ortho received the highest number and dollar amount of payments, with 315,664 payments valuing nearly $600 million. Urologists received 207,961 payments at $33.5 million, Plastics with 58,446 at $93 million, and ENT with 70,006 payments and $13.7 million. The specialties had statistically significantly different distribution of payments in total number and amount of money paid (P <.0001). PU received 906 payments and $162,826, versus OU with 207,055 payments valuing $33.4 million, and the distribution of these payments was also significantly different (P <.0001).
Conclusion
The distribution of payments differed significantly across the surgical sub-specialties examined. There was also a staggering difference in industry payments between PU and other urologists, which highlights a disparity in interactions between medical device and pharmaceutical companies even within the specialty of urology.
期刊介绍:
Urology is a monthly, peer–reviewed journal primarily for urologists, residents, interns, nephrologists, and other specialists interested in urology
The mission of Urology®, the "Gold Journal," is to provide practical, timely, and relevant clinical and basic science information to physicians and researchers practicing the art of urology worldwide. Urology® publishes original articles relating to adult and pediatric clinical urology as well as to clinical and basic science research. Topics in Urology® include pediatrics, surgical oncology, radiology, pathology, erectile dysfunction, infertility, incontinence, transplantation, endourology, andrology, female urology, reconstructive surgery, and medical oncology, as well as relevant basic science issues. Special features include rapid communication of important timely issues, surgeon''s workshops, interesting case reports, surgical techniques, clinical and basic science review articles, guest editorials, letters to the editor, book reviews, and historical articles in urology.